- IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- IMCD publishes convocation for its upcoming Annual General Meeting
- IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
- IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano
- IMCD announces dividend proposal and Supervisory Board nominations for reappointment
- IMCD reports EBITA of EUR 515 million in 2023
- IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem
More ▼
Key statistics
On Friday, IMCD NV (IMCDY:PKL) closed at 71.26, 24.05% above the 52 week low of 57.44 set on Oct 18, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 70.92 |
---|---|
High | 71.39 |
Low | 70.59 |
Bid | -- |
Offer | -- |
Previous close | 71.05 |
Average volume | 26.19k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 1.21 USD |
---|---|
Annual div yield (ADY) | 1.70% |
Div ex-date | May 16 2024 |
Div pay-date | Jun 05 2024 |
Data delayed at least 15 minutes, as of Jul 26 2024 20:50 BST.
More ▼